Arcturus Therapeutics Holdings Inc
ARCT
NASDAQ
Biotechnology
$8.23
USD
+0.37 (+4.71%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $222.41M
Volume 930.3K
Price Target
$27.00 – $27.00
USD
The 1 analysts offering 1-year price forecasts have a max estimate of $27.00 and a min estimate of $27.00.
Past 2Y
1Y Forecast
Price Targets
Average Target
$27.00
+$8.0 vs prior
Implied Upside
+228.1%
+97.2% vs prior
Analyst Covering
1
-3 vs prior period
Consensus
Buy
Improved vs prior
Signal Quality
Consensus Freshness
20%
Many ratings are older - consensus may be less current
Analyst Agreement
High
Targets are closely clustered - analysts agree more than usual
Mean vs Median
$0 Gap
Median and average are closely aligned - few outliers skewing the consensus
Analyst Consensus
Strong Sell
Hold
Strong Buy
Buy
1 Buy
0 Hold
0 Sell
Rating Breakdown
Strong Buy
0
Buy
1
Hold
0
Sell
0
Strong Sell
0
1 analysts · last 3 months
Covering Analysts
Unlock each analyst's profile, success rate + price targets
Free shows the consensus and each analyst's current rating.
| Analyst | Firm | Rating | Action | Date | Success Rate | Price Target | Implied Upside |
|---|---|---|---|---|---|---|---|
Ilya Zubkov | Freedom Capital Markets | Buy | Initiated | 1 month ago | Plus | Plus | Plus |
Frequently Asked Questions
Similar Stocks
AKBA
Akebia Therapeutics Inc
$0.8700
▲ +0.4%
GLSI
Greenwich Lifesciences Inc
$16.80
▲ +2.6%
CNXU
Conexeu Sciences Inc
$8.90
▲ +11.7%
TARA
Protara Therapeutics Inc
$3.97
▲ +0.8%
ORGO
Organogenesis Holdings Inc
$1.79
▲ +1.7%
ALEC
Alector Inc
$1.96
▼ -3.9%
NBP
NovaBridge Biosciences
$1.96
▲ +3.2%
RCEL
AVITA Medical Inc
$7.85
▼ -2.0%
IMUX
Immunic Inc
$16.06
▼ -3.1%